InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Fambrough Douglas, Chairman & CEO. Insider active across 1 company, notably Dicerna Pharmaceuticals Inc. Cumulatively, 4 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €94k. History available since 10 August 2021. The latest transaction was disclosed on 28 December 2021 (Disposition). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Fambrough Douglas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
231,431 shares@ US$38.2597.7% of flowCommon StockSEC:0001399529-21-000198:0
13,750 sharesCommon StockSEC:0001399529-21-000174:0
33,670 shares@ US$2.971.1% of flowCommon StockSEC:0001399529-21-000162:0
5,000 shares@ US$22.0961.2% of flowCommon StockSEC:0001399529-21-000146:0
Canonical exit: 8 Nov 2021 (T+90)
4 of 4 declarations
About Fambrough Douglas
Douglas Fambrough is President and CEO of Dicerna Pharmaceuticals Inc. He leads the company with a focus on innovation and the development of new therapies. His leadership is pivotal to Dicerna's mission.
